성장호르몬결핍성 환아에서 혈중 1형 인슐린양 성장인자(IGF-I)와 약물자극으로 분비된 성장호르몬과의 연관성

Cited 0 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.authorPil-Soo Oh-
dc.contributor.authorKee-Jong Kim-
dc.contributor.authorYoung-E Yoo-
dc.contributor.authorIn-June Sul-
dc.contributor.authorJae Hoon Shin-
dc.contributor.authorYoung Ik Lee-
dc.date.accessioned2017-04-19T08:54:23Z-
dc.date.available2017-04-19T08:54:23Z-
dc.date.issued1995-
dc.identifier.issn0560-3560-
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/4010-
dc.description.abstractPurpose : This study aimed to determine the best cutoff line for insulin-like growth factor (IGF)-I and insulin-like growth factor binding protein (IGFBP)-3 to discriminate between growth hormone de ficiency (GHD) patients and the control group. Methods : Two hundred thirty subjects with normal controls (129 boys and 101 girls, aged 7-15 years), 14 patients with complete GHD (12 boys and 2 girls), and 17 patients with partial GHD (9 boys and 8 girls) were studied. IGF-I serum concentrations were measured by radioimmunoassay (RI), and IGFBP-3 concentrations were measured by immunoradiometric assay (IRMA). Results : The receiver operating characteristic (ROC) plot analysis showed that the best IGF-I and IGFBP-3 cutoff line was at -1 standard deviation (SD). By comparing IGF-I serum levels of GHD children within 1 SD of normal control, we determined the sensitivity (S) (87.5-100%) and specificity (Sp) (80-84.6%) according to the age group. For IGFBP-3, we determined the following values: S (58.7-85.7%) and Sp (79.2-85.5%). Eleven of 14 patients with complete GHD (78.5%) and 16 of 17 patients with partial GHD (94.1%) had IGF-I concentrations equal to or below -1 SD of the control group mean. Ten of 12 complete GHD children (83.3%) and 13 of 17 partial GHD children (76.5%) had IGFBP-3 concentrations equal or below -1 SD of the control group mean. Conclusion : We conclude that the measurement of IGF-I and IGFBP-3 concentrations might provide essential supplementary data in the diagnostic evaluation of patients with GHD. Our results support the need to use cutoff lines based on below -1 SD of the control.-
dc.publisherKorea Soc-Assoc-Inst-
dc.title성장호르몬결핍성 환아에서 혈중 1형 인슐린양 성장인자(IGF-I)와 약물자극으로 분비된 성장호르몬과의 연관성-
dc.title.alternative성장호르몬결핍성 환아에서 혈중 1형 인슐린양 성장인자(IGF-I)와 약물자극으로 분비된 성장호르몬과의 연관성-
dc.typeArticle-
dc.citation.titleJournal of Korean Pediatric Society-
dc.citation.number10-
dc.citation.endPage1403-
dc.citation.startPage1394-
dc.citation.volume38-
dc.contributor.affiliatedAuthorPil-Soo Oh-
dc.contributor.affiliatedAuthorKee-Jong Kim-
dc.contributor.affiliatedAuthorYoung-E Yoo-
dc.contributor.affiliatedAuthorIn-June Sul-
dc.contributor.affiliatedAuthorJae Hoon Shin-
dc.contributor.affiliatedAuthorYoung Ik Lee-
dc.contributor.alternativeName오필수-
dc.contributor.alternativeName김기종-
dc.contributor.alternativeName유영이-
dc.contributor.alternativeName설인준-
dc.contributor.alternativeName신재훈-
dc.contributor.alternativeName이영익-
dc.identifier.bibliographicCitationJournal of Korean Pediatric Society, vol. 38, no. 10, pp. 1394-1403-
dc.subject.keywordInsulin-like growth factor-I-
dc.subject.keywordInsulin-like growth factor binding protein-3-
dc.subject.keywordGrowth hormone de ficiency-
dc.subject.localInsulin-like growth factor-I-
dc.subject.localInsulin-like growth factor-Ⅰ(IGF-Ⅰ)-
dc.subject.localinsulin-like growth factor I-
dc.subject.localinsulin-like growth factor I (IGF-I)-
dc.subject.localinsulin-like growth factor type 1-
dc.subject.localinsulin-like growth factor-Ⅰ(IGF-Ⅰ)-
dc.subject.localInsulin-like growth factor binding protein-3-
dc.subject.localinsulin-like growth factor binding protein-3-
dc.subject.localGrowth hormone de ficiency-
dc.description.journalClassN-
Appears in Collections:
1. Journal Articles > Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.